发明名称 |
FORMULATION OF TOCOTRIENOL QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES |
摘要 |
A formulation, comprising an ophthalmically effective amount of one or more tocotrienol quinones, particularly of alpha-tocotrienol quinone is disclosed. Use of a formulation comprising one or more tocotrienol quinones for the prevention, reduction, amelioration or treatment of ophthalmic disorders that are associated with a neurodegenerative or trauma disorder is also discussed. A method of treating or controlling the ocular symptoms associated with neurodegenerative diseases or trauma with a formulation comprising one or more tocotrienol quinones is also discussed. A method of treating or controlling the ocular symptoms associated with mitochondrial myopathies with a formulation comprising one or more tocotrienol quinones is also discussed. |
申请公布号 |
CA2759984(A1) |
申请公布日期 |
2010.11.04 |
申请号 |
CA20102759984 |
申请日期 |
2010.04.27 |
申请人 |
EDISON PHARMACEUTICALS, INC. |
发明人 |
MILLER, GUY M.;SHRADER, WILLIAM D.;KHEIFETS, VIKTORIA |
分类号 |
A61K9/00;A61K9/14;A61K31/05;A61K31/122;A61P25/02;A61P25/16;A61P25/28;A61P27/02;A61P27/06 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|